{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:38:30Z","timestamp":1754163510685,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pulmonary lymphoepithelioma-like carcinoma (pLELC) is a rare subtype of non-small cell lung cancer (NSCLC) that is closely associated with Epstein-Barr virus (EBV) infection. While radiotherapy after induction chemotherapy have shown marked efficacy in nasopharyngeal carcinoma (NPC), its effectiveness in pLELC remains uncertain. A female with stage IIIB pLELC was treated with 4 cycles of gemcitabine plus cisplatin, achieving partial response(PR), followed by radical radiotherapy. Patients achieved clinical complete response(CR) with recurrence-free for over five years. This case highlights the potential of induction chemotherapy as an effective treatment for locally advanced pLELC.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1605900","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:37:52Z","timestamp":1753940272000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Induction chemoradiotherapy achieves long-term recurrence-free survival in locally advanced pulmonary lymphoepithelioma-like carcinoma: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Gengda","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinqin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiexia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12032-020-1344-3","article-title":"Primary pulmonary lymphoepithelioma-like carcinoma","volume":"37","author":"Fan","year":"2020","journal-title":"Med Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1309\/BUAN-BGFW-69U9-C3H8","article-title":"Lymphoepithelioma-like carcinoma of the lung with a better prognosis. A clinicopathologic study of 32 cases","volume":"115","author":"Han","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.31557\/APJCP.2024.25.6.1997","article-title":"Tumor infiltrating lymphocytes as an independent prognostic factor in undifferentiated nasopharyngeal carcinoma","volume":"25","author":"Febriani","year":"2024","journal-title":"Asian Pac J Cancer Prev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01693-21","article-title":"Genomic landscapes of epstein-barr virus in pulmonary lymphoepithelioma-like carcinoma","volume":"96","author":"Wu","year":"2022","journal-title":"J Virol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12931-019-1236-2","article-title":"Primary pulmonary\u00a0lymphoepithelioma-like carcinoma: a rare type of lung cancer with a favorable outcome in comparison to squamous carcinoma","volume":"20","author":"Chen","year":"2019","journal-title":"Respir Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.626566","article-title":"Immune checkpoint blockade therapy may be a feasible option for primary pulmonary lymphoepithelioma-like carcinoma","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930360413","article-title":"Epstein-barr virus related lymphoepithelioma-like carcinoma of lung","volume":"36","author":"B\u00e9gin","year":"1987","journal-title":"J Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-4296(03)00034-1","article-title":"Radiation-induced lung injury","volume":"13","author":"Marks","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose\u2013volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2018.12.014","article-title":"Clinical features and prognosis of pulmonary lymphoepithelioma-like carcinoma: summary of eighty-five cases","volume":"20","author":"Qin","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2308-5","article-title":"A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401","volume":"72","author":"Oh","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non\u2013small cell lung cancer, version 4.2024","volume":"22","author":"Riely","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2015.03.017","article-title":"PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy","volume":"88","author":"Chang","year":"2015","journal-title":"Lung Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.820302","article-title":"Comparison of immunotherapy, chemotherapy, and chemoimmunotherapy in advanced pulmonary lymphoepithelioma-like carcinoma: A retrospective study","volume":"12","author":"Xiao","year":"2022","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"108057","DOI":"10.1016\/j.lungcan.2024.108057","article-title":"Perioperative immunotherapy plus chemotherapy versus chemotherapy alone for patients with resectable pulmonary lymphoepithelioma-like carcinoma","volume":"199","author":"Lei","year":"2025","journal-title":"Lung Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00594-4","article-title":"Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial","volume":"403","author":"Liu","year":"2024","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.humpath.2018.11.002","article-title":"The implication of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric carcinoma","volume":"85","author":"Gong","year":"2019","journal-title":"Hum Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1864","article-title":"Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors","volume":"14","author":"Fu","year":"2008","journal-title":"Nat Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1038\/s41467-019-10902-w","article-title":"The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma","volume":"10","author":"Hong","year":"2019","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"109937","DOI":"10.1016\/j.radonc.2023.109937","article-title":"Treatment options for stage III-N2 pulmonary lymphoepithelioma-like carcinoma: A retrospective cohort study","volume":"189","author":"Hou","year":"2023","journal-title":"Radiother Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27452","article-title":"Primary pulmonary lymphoepithelioma-like carcinoma","volume":"118","author":"Liang","year":"2012","journal-title":"Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-018-0570-1","article-title":"Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis","volume":"208","author":"Yin","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13046-023-02835-6","article-title":"Anoikis resistance and\u00a0immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1\u03b1 promotes invasion and metastasis of nasopharyngeal carcinoma","volume":"42","author":"Liao","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01850-12","article-title":"The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli","volume":"86","author":"Hagemeier","year":"2012","journal-title":"J Virol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for epstein-barr virus-positive B-cell lymphomas","volume":"78","author":"Feng","year":"2004","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46006","article-title":"Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy","volume":"10","author":"Hu","year":"2020","journal-title":"Theranostics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.10.031","article-title":"Clinical significance of plasma epstein-barr virus DNA in pulmonary lymphoepithelioma-like carcinoma (LELC) patients","volume":"13","author":"Xie","year":"2018","journal-title":"J Thorac Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605900\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:37:52Z","timestamp":1753940272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605900\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2025.1605900"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605900","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"article-number":"1605900"}}